Cancer warning on menopause drug

WOMEN with a history of breast cancer are being urged to avoid taking a menopause drug now known to greatly increase the risk of the cancer returning.

Results of a study published yesterday found that a synthetic steroid, called tibolone, increases the chances of breast cancer returning by 40%.

More than two-thirds of the recurrences involved aggressive spreading tumours that are invariably fatal.